ARTICLE | Company News
Argyle Therapeutics, Brickell Biotech Inc deal
April 23, 2012 7:00 AM UTC
Argyle granted Brickell exclusive, worldwide rights to develop and commercialize SIG990 for dermatology indications. Argyle is eligible for milestones and royalties. The topical anti-inflammatory sma...